title: Development of progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma 13 years after treatment with cladribine.
authors.forename: Martin
authors.initials: M
authors.lastname: Berghoff
authors.forename: Anne
authors.initials: A
authors.lastname: Schänzer
authors.forename: Gerhard C
authors.initials: GC
authors.lastname: Hildebrandt
authors.forename: Benjamin
authors.initials: B
authors.lastname: Dassinger
authors.forename: Gothje
authors.initials: G
authors.lastname: Klappstein
authors.forename: Manfred
authors.initials: M
authors.lastname: Kaps
authors.forename: Elke R
authors.initials: ER
authors.lastname: Gizewski
authors.forename: Till
authors.initials: T
authors.lastname: Acker
authors.forename: Astrid
authors.initials: A
authors.lastname: Grams
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D017338:Cladribine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007968:Leukoencephalopathy, Progressive Multifocal / Q000175:diagnosis / Q000209:etiology*; D008228:Lymphoma, Non-Hodgkin / Q000150:complications* / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D008875:Middle Aged
chemical_list: D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D017338:Cladribine